Key Insights

Highlights

Success Rate

98% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

1.7%

1 terminated out of 58 trials

Success Rate

97.8%

+11.3% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

18%

8 of 44 completed with results

Key Signals

8 with results98% success

Data Visualizations

Phase Distribution

58Total
Not Applicable (9)
Early P 1 (3)
P 1 (44)
P 2 (2)

Trial Status

Completed44
Recruiting10
Not Yet Recruiting3
Terminated1

Trial Success Rate

97.8%

Benchmark: 86.5%

Based on 44 completed trials

Clinical Trials (58)

Showing 20 of 20 trials
NCT07511400Early Phase 1Recruiting

The Role of NaV1.8 in Human Pain Models

NCT07314346Phase 1RecruitingPrimary

Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadone

NCT06911320Phase 1RecruitingPrimary

Study of Bemnifosbuvir/Ruzasvir as a Fixed-dose Combination in Subjects With Normal or Severely Impaired Renal or Hepatic Function

NCT07272889Phase 1CompletedPrimary

Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Ethinyl Estradiol/Levonorgestrel (EE/LNG)

NCT06636500Phase 1CompletedPrimary

A Phase 1 Study of CG001419 Administered Orally in Healthy Subjects

NCT06825364Not ApplicableRecruiting

Near-InfraRed Spectroscopy of Auricular Stimulation

NCT06608433Not ApplicableCompletedPrimary

Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function

NCT06983730Early Phase 1Recruiting

The Kidney's Response to Exercise in Heat, and the Impact of Vitamin B3 on This Response

NCT06757738Phase 1CompletedPrimary

A Clinical Study Aiming to Assess Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of TRX-100 in Healthy Volunteers

NCT07021079Not ApplicableRecruiting

Muscle Vibration as a Countermeasure Against Hypoactivity-induced

NCT06741345Phase 1CompletedPrimary

Phase 1 BIO 300 Oral Suspension

NCT05881993Early Phase 1CompletedPrimary

Study of CBP-4888 in Healthy, Non-Pregnant Female Subjects

NCT07007806Phase 1CompletedPrimary

Drug-drug Interaction Study of Omeprazole and Bemnifosbuvir/Ruzasvir

NCT06921941Phase 1CompletedPrimary

Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Digoxin and Rosuvastatin

NCT07099612Not ApplicableCompletedPrimary

Smart Blister Packaging and Mobile Application to Monitor and Support Medication Adherence: a Two-arm Usability Study

NCT06959888Phase 1CompletedPrimary

A Phase 1 Study in Healthy Volunteers to Evaluate the Relative Bioavailability of ALG-055009 Formulations

NCT07034014Not ApplicableRecruitingPrimary

An Investigation to Evaluate Wearing Properties of Three Different Investigational Devices

NCT06996704Phase 1RecruitingPrimary

A Clinical Study of AK0610

NCT06988397Not ApplicableNot Yet Recruiting

Stomach Processing and Emptying Evaluation With Diet and Ultrasound

NCT06118385Phase 1CompletedPrimary

Study Investigating the Safety, Tolerability, PK and Food Effect of BEN8744.

Scroll to load more

Research Network

Activity Timeline